GS6 Forefront Researches of Drug Innovation Technology in the Post-Genomic Era – Studies of Biomarker Discovery for Drug Development – GS6-1 Evaluation of Biological Influence of Nano-materials using Toxicokinetics and Toxicoproteomics GS6-2 Proteomic identification and characterization of the new functional proteins in the EGF receptor-mediated signaling pathway GS6-3 Antibody-based proteomics for discovery of tumor organization blood vessel biomarkers and development of this antibody GS6-4 From disease proteomics to biomarker development -Establishment of antibody proteomics technology and exploration of cancer-related biomarkers-